Pelvic actinomycosis von Floyd, R, Hunter, S, Abu Saadeh, F, McDonnell, C, McCormick, P

Volltext

Extended thromboprophylaxis post gynaecological cancer surgery; the effect of weight adjusted and fixed dose LMWH (Tinzaparin) von Abu Saadeh, F., Marchocki, Z., O'Toole, S.A., Ibrahim, N., Gleeson, N., Norris, L.A.

Volltext

P-077: Risk of recurrence of venous thromboembolism in patients with gynaecological cancer von Marchocki, Z, Abu Saadeh, F, Gleeson, N, Norris, L

Volltext

Procoagulant activity in gynaecological cancer patients; the effect of surgery and chemotherapy von Abu Saadeh, F, Langhe, R, Galvin, D.M, O Toole, S.A, O'Donnell, D.M, Gleeson, N, Norris, L.A

Volltext

OC-12 - Peri operative venous thromboembolism prophylaxis in gynaecological cancer patients. A survey of current practice von Petch, S, Norris, L.A, O’Toole, S.A, Gleeson, N, Saadeh, F. Abu

Volltext

PO-24 - Determinants of thrombin generation in gynaecological malignancies von Norris, L.A, Martin, F.A, O’Toole, S.A, Saadeh, F. Abu, Gleeson, N

Volltext

PO-14 - Tumour expression of coagulation proteases of the aPC pathway – a role in the pathogenesis of gynaecological cancers? von Martin, F, Long, J.C, O’Toole, S.A, O’Leary, J.J, Abu Saadeh, F, Gleeson, N, Norris, L.A

Volltext

P.86 The role of tissue factor and tissue factor pathway inhibitor in ovarian cancer von Abu Saadeh, F, Norris, L, O'Toole, S, Gleeson, N

Volltext

PO-06: Thrombomodulin as a marker for VTE following neoadjuvant chemotherapy von Ward, M.P., Ibrahim, E., O’Toole, S., Gleeson, N., Abu Saadeh, F., O’Donnell, D., Norris, L.A.

Volltext

PO-03 Is extended thromboprophylaxis required for all gynaecological cancer patients post-surgery? von Abu Saadeh, F., Marchocki, Z., O’Toole, S.A., Gleeson, N., Kashan, A., Norris, L.A.

Volltext

The empty pelvis syndrome: a core data set from the PelvEx collaborative von Aziz, NA, Abraham-Nordling, M, Akiyoshi, T, Alahmadi, R, Andric, M, Austin, KK, Aytac, E, Bali, M, Baransi, S, Berg, PL, Bergzoll, C, Boyle, K, Bremers, AB, Brunner, M, Burgess, A, Campain, N, Chok, AK, Chong, P, Clouston, H, Colquhoun, AJ, Constantinides, J, Cotsoglou, C, Damjanovic, L, Davies, RJ, de Wilt, JHW, Deutsch, C, Espin-Basany, E, Eyjolfsdottir, B, Fleming, F, Garcia-Granero, E, Garcia-Sabrido, JL, Gentilini, L, Gomez, CM, Harris, C, Hanchanale, Hochman, D, Hohenberger, W, Holmstrom, A, Hompes, R, Hurton, S, Kanemitsu, Y, Keller, DS, Khan, MS, Khaw, J, Kim, HJ, Koh, CE, Kristensen, HO, Lakkis, Z, Larson, DW, Mantyh, C, Meijerink, WJHJ, Malde, S, Mikalauskas, S, Morton, JR, Nielsen, MB, Nieuwenhuijzen, GAP, Nilsson, PJ, Nordkamp, S, O'Dwyer, ST, Pappou, E, Patsouras, D, Peacock, O, Piqeur, F, Proud, D, Quinn, M, Rajendran, N, Rao, C, Rasheed, S, Rausa, E, Reims, HM, Rintala, J, Rohila, J, Sahai, A, Scripcariu, D, Seifert, G, Shaikh, Shida, D, Simpson, A, Skeie-Jensen, T, Smart, P, Solbakken, AM, Stocchi, L, Taylor, D, Tejedor, P, Thurairaja, R, Tsukamoto, S, Tuech, JJ, Turner, G, Turner, WH, Valente, M, van Rees, J, van Zoggel, D, Vasquez-Jimenez, W, Uehara, K, Warrier, S, Wheeler, JMD, Wild, J, Wilson, M, Yip, J, Zappa, MA

Volltext

Development and validation of a risk model for prediction of venous thromboembolism in gynaecological cancer patients von Norris, L.A., Abu Saadeh, F., Ward, M., O'Toole, S.A., Machocki, Z., Ibrahim, N., Gleeson, N.

Volltext

Fibrinogen, D-Dimers and thrombin generation assays as predictors of the risk of recurrent VTE in patients with gynaecological malignancies von Marchocki, Z., Gleeson, N., Abu Saadeh, F., Ward, M.P., O’Toole, S.A., Norris, L.A.

Volltext

Patients experience and compliance with extended LMWH prophylaxis post-surgery for gynaecological cancer von Marchocki, Z., Norris, L.N., O’Toole, S.A., Gleeson, N., Abu Saadeh, F.

Volltext

Contemporary Management of Locally Advanced and Recurrent Rectal Cancer: Views from the PelvEx Collaborative von PelvEx Collaborative, PelvEx Collaborative

Volltext

TEMPORARY REMOVAL: PO-06: Thrombomodulin as a marker for VTE following neoadjuvant chemotherapy von Ward, M P, Ibrahim, E, O'Toole, S, Gleeson, N, Abu Saadeh, F, O'Donnell, D, Norris, L A

Volltext

PO-22 Does tissue factor and tissue factor pathway inhibitor over expression, play a role in the development of venous thromboembolism in ovarian cancer patients? von Saadeh, F. Abu, Norris, L., O'Toole, S., Langhe, R., O'Leary, J.J., Gleeson, N.

Volltext

PO-76 Procoagulant activity in patients with gynaecological malignancies and the effect of neoadjuvant chemotherapy von Saadeh, F. Abu, Norris, L., O'Toole, S., Langhe, R., Gleeson, N.

Volltext

Procoagulant activity in patients with gynaecological malignancies and the effect of neoadjuvant chemotherapy von Saadeh, F. Abu, Norris, L, O'Toole, S, Langhe, R, Gleeson, N

Volltext

Does tissue factor and tissue factor pathway inhibitor over expression, play a role in the development of venous thromboembolism in ovarian cancer patients? von Saadeh, F. Abu, Norris, L, O'Toole, S, Langhe, R, O'Leary, J.J, Gleeson, N

Volltext